JP6010120B2 - 膣内送達システム - Google Patents

膣内送達システム Download PDF

Info

Publication number
JP6010120B2
JP6010120B2 JP2014520613A JP2014520613A JP6010120B2 JP 6010120 B2 JP6010120 B2 JP 6010120B2 JP 2014520613 A JP2014520613 A JP 2014520613A JP 2014520613 A JP2014520613 A JP 2014520613A JP 6010120 B2 JP6010120 B2 JP 6010120B2
Authority
JP
Japan
Prior art keywords
acid
delivery system
intravaginal delivery
weight
eva
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014520613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014520871A5 (enExample
JP2014520871A (ja
Inventor
パウル リモン，ジャン
パウル リモン，ジャン
ヴェルヴィート，クリス
ヴェルシュトラーレン，ハンス
テメルマン，マルレーン
Original Assignee
ウニベルシテイト ヘント
ウニベルシテイト ヘント
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ウニベルシテイト ヘント, ウニベルシテイト ヘント filed Critical ウニベルシテイト ヘント
Publication of JP2014520871A publication Critical patent/JP2014520871A/ja
Publication of JP2014520871A5 publication Critical patent/JP2014520871A5/ja
Application granted granted Critical
Publication of JP6010120B2 publication Critical patent/JP6010120B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2014520613A 2011-07-15 2012-07-12 膣内送達システム Expired - Fee Related JP6010120B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11174103 2011-07-15
EP11174103.9 2011-07-15
PCT/EP2012/063702 WO2013010915A1 (en) 2011-07-15 2012-07-12 Intravaginal delivery system

Publications (3)

Publication Number Publication Date
JP2014520871A JP2014520871A (ja) 2014-08-25
JP2014520871A5 JP2014520871A5 (enExample) 2015-08-13
JP6010120B2 true JP6010120B2 (ja) 2016-10-19

Family

ID=46579003

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520613A Expired - Fee Related JP6010120B2 (ja) 2011-07-15 2012-07-12 膣内送達システム

Country Status (5)

Country Link
US (1) US9168303B2 (enExample)
EP (1) EP2731587B1 (enExample)
JP (1) JP6010120B2 (enExample)
CN (1) CN103648482B (enExample)
WO (1) WO2013010915A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170319833A1 (en) * 2010-03-28 2017-11-09 Evestra, Inc. Intravaginal drug delivery device
JP2015505707A (ja) * 2011-12-16 2015-02-26 コンビネント・バイオメデイカル・システムズ・インコーポレーテツド 腟内薬剤投与装置および製法
CN104274388B (zh) * 2014-09-28 2017-02-15 南京泽恒医药技术开发有限公司 维生素c缓释栓剂组合物及制备方法
US11472950B2 (en) * 2016-12-21 2022-10-18 Braskem S.A. Modified ethylene vinyl acetate compositions, polymer blends and films made therefrom
JP2021528452A (ja) * 2018-06-25 2021-10-21 タイタン ファーマシューティカルズ インコーポレイテッド インプラントとして使用するための装填可能な多孔質構造
KR102078462B1 (ko) * 2018-07-24 2020-02-17 주식회사 디네이쳐 질환경 개선 조성물 및 이를 포함하는 개선제
CN112569225B (zh) * 2019-09-27 2022-10-21 共生地球生物科技有限公司 非药物幽门杆菌杀菌组合物
KR20210097421A (ko) * 2020-01-30 2021-08-09 주식회사 디네이쳐 펄스형 질내 약산성 환경 유지 조성물
CA3167761C (en) * 2020-02-12 2025-05-20 Shenzhen Eulikan Biotechnology Co., Ltd BACTERIOSTATIC COMPOSITION, PREPARATION PROCESS AND USE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543150A (en) * 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
JP4898431B2 (ja) 2003-04-29 2012-03-14 ザ ジェネラル ホスピタル コーポレイション 複数薬物の持続放出のための方法およびデバイス
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
ES2371554T3 (es) 2004-12-14 2012-01-05 Poly-Med, Inc. Dispositivo intravaginal de malla en forma de anillo.
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
WO2009129459A1 (en) * 2008-04-18 2009-10-22 Combinent Biomedical Systems, Inc. Devices that include ethylene-vinyl acetate copolymers and methods of making and using same
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
CN103298519B (zh) * 2010-11-12 2016-09-14 犹他大学研究基金会 用于受控式润滑剂传递的阴道内装置

Also Published As

Publication number Publication date
WO2013010915A1 (en) 2013-01-24
US9168303B2 (en) 2015-10-27
EP2731587B1 (en) 2024-12-04
JP2014520871A (ja) 2014-08-25
CN103648482B (zh) 2018-01-02
CN103648482A (zh) 2014-03-19
EP2731587A1 (en) 2014-05-21
US20140154293A1 (en) 2014-06-05

Similar Documents

Publication Publication Date Title
US9168303B2 (en) Intravaginal delivery system
Ball et al. Drug-eluting fibers for HIV-1 inhibition and contraception
EP3178469A2 (en) Vaginal composition for the treatment of urogenital infections
Sanz et al. Development of a mucoadhesive delivery system for control release of doxepin with application in vaginal pain relief associated with gynecological surgery
JP2014012675A (ja) 婦人科の障害の治療における乳酸オリゴマーの使用
CZ286831B6 (en) Preparation applicable through vagina for maintaining healthy intravaginal bacterial flora and for prevention sexually contagious diseases
Ahmad et al. Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections
ES2652251T3 (es) Composiciones farmacéuticas que contienen ácido láctico oligomérico
Fernando et al. Controlled delivery of the antiprotozoal agent (tinidazole) from intravaginal polymer matrices for treatment of the sexually transmitted infection, trichomoniasis
Fernandes et al. pH-triggered polymeric nanoparticles in gel for preventing vaginal transmission of HIV and unintended pregnancy
Borges et al. Drug delivery systems for vaginal infections
CN118076341A (zh) 用于治疗贮袋炎和远端溃疡性结肠炎的利福霉素的原位胶凝化灌肠剂
CN115590892A (zh) 一种含益生菌复合粉的女性私密益生菌抑菌粉及制备方法
US11672757B2 (en) Hot melt extrusion for pharmaceutical vaginal film products
CN121175031A (zh) 多组分阴道内环
CN109966271A (zh) 一种盐酸莫西沙星膜剂及其制备方法
HK1195746A (en) Intravaginal delivery system
HK1195746B (en) Intravaginal delivery system
El-Salamouni et al. Preparation and evaluation of vaginal suppo-sponges loaded with benzydamine, in-vitro/in-vivo study
Pandey et al. Miniaturized polymeric systems for the intravaginal gene therapies: Recent update on unconventional delivery
Tomás Innovative therapeutic strategies for the treatment of vaginal infections
Chen Development and evaluation of novel intravaginal rings fabricated via hot-melt extrusion-based technologies as innovative microbicides
KR20250162796A (ko) 보호용 생체반응성 중합체 씰
RU2812223C2 (ru) Применение тотарола и фармацевтическая композиция, содержащая тотарол
Pathak Controlled delivery of antibacterials using polycaprolactone matrices for the intravaginal treatment of sexually transmitted infections

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150624

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150624

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160518

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160621

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160621

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160825

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160915

R150 Certificate of patent or registration of utility model

Ref document number: 6010120

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees